{"id":"https://openalex.org/W2043788512","doi":"https://doi.org/10.1016/j.drudis.2011.04.011","title":"A generic operational strategy to qualify translational safety biomarkers","display_name":"A generic operational strategy to qualify translational safety biomarkers","publication_year":2011,"publication_date":"2011-05-07","ids":{"openalex":"https://openalex.org/W2043788512","doi":"https://doi.org/10.1016/j.drudis.2011.04.011","mag":"2043788512","pmid":"https://pubmed.ncbi.nlm.nih.gov/21570476"},"language":"en","primary_location":{"id":"doi:10.1016/j.drudis.2011.04.011","doi":"https://doi.org/10.1016/j.drudis.2011.04.011","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.drudis.2011.04.011","pdf_url":null,"source":{"id":"https://openalex.org/S152068293","display_name":"Drug Discovery Today","issn_l":"1359-6446","issn":["1359-6446","1878-5832"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-1","medline","norway-1","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Drug Discovery Today","raw_type":"journal-article"},"volume":null,"type":"review","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5021611956","display_name":"Katja A. Matheis","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1330995197","display_name":"Boehringer Ingelheim (Germany)","ror":"https://ror.org/00q32j219","country_code":"DE","type":"company","lineage":["https://openalex.org/I1330995197"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Katja Matheis","raw_affiliation_strings":["Boehringer-Ingelheim Pharma GmbH & Co. KG, Biberach, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Boehringer-Ingelheim Pharma GmbH & Co. KG, Biberach, Germany","institution_ids":["https://openalex.org/I1330995197"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5013746790","display_name":"David Laurie","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1283582996","display_name":"Novartis (Switzerland)","ror":"https://ror.org/02f9zrr09","country_code":"CH","type":"company","lineage":["https://openalex.org/I1283582996"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"David Laurie","raw_affiliation_strings":["Novartis Pharma AG, Basel, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Novartis Pharma AG, Basel, Switzerland","institution_ids":["https://openalex.org/I1283582996"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5074325930","display_name":"Christiane Andriamandroso","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210164541","display_name":"Interface Europe (Belgium)","ror":"https://ror.org/05kxkjm75","country_code":"BE","type":"company","lineage":["https://openalex.org/I4210164541"]}],"countries":["BE"],"is_corresponding":false,"raw_author_name":"Christiane Andriamandroso","raw_affiliation_strings":["Interface Europe, Brussels, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Interface Europe, Brussels, Belgium","institution_ids":["https://openalex.org/I4210164541"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5029751327","display_name":"Nadir Arber","orcid":"https://orcid.org/0000-0001-5283-6991","observed_orcids":["https://orcid.org/0000-0001-5283-6991","https://orcid.org/0000-0002-3881-9228"]},"institutions":[{"id":"https://openalex.org/I2799807261","display_name":"Tel Aviv Sourasky Medical Center","ror":"https://ror.org/04nd58p63","country_code":"IL","type":"healthcare","lineage":["https://openalex.org/I2799807261"]}],"countries":["IL"],"is_corresponding":false,"raw_author_name":"Nadir Arber","raw_affiliation_strings":["Tel-Aviv (Souraski) Medical Center, Tel-Aviv, Israel"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Tel-Aviv (Souraski) Medical Center, Tel-Aviv, Israel","institution_ids":["https://openalex.org/I2799807261"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5004801541","display_name":"Lina Badim\u00f3n","orcid":"https://orcid.org/0000-0002-9162-2459","observed_orcids":["https://orcid.org/0000-0002-9162-2459"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Lina Badimon","raw_affiliation_strings":["Barcelona Cardiovascular Research Center (ICCC-CISC), Barcelona, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Barcelona Cardiovascular Research Center (ICCC-CISC), Barcelona, Spain","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5018516471","display_name":"Xavier Benain","orcid":"https://orcid.org/0000-0002-3414-1325","observed_orcids":["https://orcid.org/0000-0002-3414-1325"]},"institutions":[{"id":"https://openalex.org/I3018075036","display_name":"Sanofi (France)","ror":"https://ror.org/02n6c9837","country_code":"FR","type":"company","lineage":["https://openalex.org/I3018075036"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Xavier Benain","raw_affiliation_strings":["Sanofi-Aventis, Paris, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sanofi-Aventis, Paris, France","institution_ids":["https://openalex.org/I3018075036"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5029162469","display_name":"Ka\u00efdre Bendjama","orcid":"https://orcid.org/0000-0003-2185-9116","observed_orcids":["https://orcid.org/0000-0003-2185-9116"]},"institutions":[{"id":"https://openalex.org/I4210111332","display_name":"Firalis (France)","ror":"https://ror.org/02s9z8855","country_code":"FR","type":"company","lineage":["https://openalex.org/I4210111332"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Ka\u00efdre Bendjama","raw_affiliation_strings":["Firalis SAS, 35 rue du Fort, 68330 Huningue, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Firalis SAS, 35 rue du Fort, 68330 Huningue, France","institution_ids":["https://openalex.org/I4210111332"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5051532540","display_name":"Isabelle Clavier","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I3018075036","display_name":"Sanofi (France)","ror":"https://ror.org/02n6c9837","country_code":"FR","type":"company","lineage":["https://openalex.org/I3018075036"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Isabelle Clavier","raw_affiliation_strings":["Sanofi-Aventis, Paris, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sanofi-Aventis, Paris, France","institution_ids":["https://openalex.org/I3018075036"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5011998301","display_name":"Peter Colman","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I189718659","display_name":"Pfizer (United Kingdom)","ror":"https://ror.org/04x4v8p40","country_code":"GB","type":"company","lineage":["https://openalex.org/I180857899","https://openalex.org/I189718659"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Peter Colman","raw_affiliation_strings":["Pfizer Ltd, Sandwich, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pfizer Ltd, Sandwich, UK","institution_ids":["https://openalex.org/I189718659"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113852198","display_name":"H\u00fcseyin Firat","orcid":"https://orcid.org/0009-0005-1692-1060","observed_orcids":["https://orcid.org/0009-0005-1692-1060"]},"institutions":[{"id":"https://openalex.org/I4210111332","display_name":"Firalis (France)","ror":"https://ror.org/02s9z8855","country_code":"FR","type":"company","lineage":["https://openalex.org/I4210111332"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"H\u00fcseyin Firat","raw_affiliation_strings":["Firalis SAS, 35 rue du Fort, 68330 Huningue, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Firalis SAS, 35 rue du Fort, 68330 Huningue, France","institution_ids":["https://openalex.org/I4210111332"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5033215245","display_name":"Jens C. Goepfert","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210111828","display_name":"Natural and Medical Sciences Institute","ror":"https://ror.org/01th1p123","country_code":"DE","type":"other","lineage":["https://openalex.org/I4210111828"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Jens Goepfert","raw_affiliation_strings":["Natural and Medical Sciences Institute, Reutlingen, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Natural and Medical Sciences Institute, Reutlingen, Germany","institution_ids":["https://openalex.org/I4210111828"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Steve Hall","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I189718659","display_name":"Pfizer (United Kingdom)","ror":"https://ror.org/04x4v8p40","country_code":"GB","type":"company","lineage":["https://openalex.org/I180857899","https://openalex.org/I189718659"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Steve Hall","raw_affiliation_strings":["Pfizer Ltd, Sandwich, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pfizer Ltd, Sandwich, UK","institution_ids":["https://openalex.org/I189718659"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5080106313","display_name":"Thomas O Joos","orcid":"https://orcid.org/0000-0003-3042-8174","observed_orcids":["https://orcid.org/0000-0003-3042-8174"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Thomas Joos","raw_affiliation_strings":["Experimental & Diagnostic Immunology GmbH, Reutlingen, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Experimental & Diagnostic Immunology GmbH, Reutlingen, Germany","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5030563138","display_name":"Sarah R. Kraus","orcid":"https://orcid.org/0000-0003-1083-0297","observed_orcids":["https://orcid.org/0000-0003-1083-0297"]},"institutions":[{"id":"https://openalex.org/I2799807261","display_name":"Tel Aviv Sourasky Medical Center","ror":"https://ror.org/04nd58p63","country_code":"IL","type":"healthcare","lineage":["https://openalex.org/I2799807261"]}],"countries":["IL"],"is_corresponding":false,"raw_author_name":"Sarah Kraus","raw_affiliation_strings":["Tel-Aviv (Souraski) Medical Center, Tel-Aviv, Israel"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Tel-Aviv (Souraski) Medical Center, Tel-Aviv, Israel","institution_ids":["https://openalex.org/I2799807261"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109864861","display_name":"Axel Kretschmer","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I67348948","display_name":"Bayer (Germany)","ror":"https://ror.org/04hmn8g73","country_code":"DE","type":"company","lineage":["https://openalex.org/I67348948"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Axel Kretschmer","raw_affiliation_strings":["Bayer Schering Pharma AG, Leverkusen, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bayer Schering Pharma AG, Leverkusen, Germany","institution_ids":["https://openalex.org/I67348948"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5012533972","display_name":"Michael Merz","orcid":"https://orcid.org/0000-0002-2758-5948","observed_orcids":["https://orcid.org/0000-0002-2758-5948"]},"institutions":[{"id":"https://openalex.org/I1283582996","display_name":"Novartis (Switzerland)","ror":"https://ror.org/02f9zrr09","country_code":"CH","type":"company","lineage":["https://openalex.org/I1283582996"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"Michael Merz","raw_affiliation_strings":["Novartis Pharma AG, Basel, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Novartis Pharma AG, Basel, Switzerland","institution_ids":["https://openalex.org/I1283582996"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5015329406","display_name":"Teresa Padr\u00f3","orcid":"https://orcid.org/0000-0003-1921-954X","observed_orcids":["https://orcid.org/0000-0003-1921-954X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Teresa Padro","raw_affiliation_strings":["Barcelona Cardiovascular Research Center (ICCC-CISC), Barcelona, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Barcelona Cardiovascular Research Center (ICCC-CISC), Barcelona, Spain","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5004102781","display_name":"Hannes Planatscher","orcid":"https://orcid.org/0000-0002-6536-0782","observed_orcids":["https://orcid.org/0000-0002-6536-0782"]},"institutions":[{"id":"https://openalex.org/I4210111828","display_name":"Natural and Medical Sciences Institute","ror":"https://ror.org/01th1p123","country_code":"DE","type":"other","lineage":["https://openalex.org/I4210111828"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Hannes Planatscher","raw_affiliation_strings":["Natural and Medical Sciences Institute, Reutlingen, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Natural and Medical Sciences Institute, Reutlingen, Germany","institution_ids":["https://openalex.org/I4210111828"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5052031647","display_name":"Annamaria Rossi","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I189718659","display_name":"Pfizer (United Kingdom)","ror":"https://ror.org/04x4v8p40","country_code":"GB","type":"company","lineage":["https://openalex.org/I180857899","https://openalex.org/I189718659"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Annamaria Rossi","raw_affiliation_strings":["Pfizer Ltd, Sandwich, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pfizer Ltd, Sandwich, UK","institution_ids":["https://openalex.org/I189718659"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5025026489","display_name":"Nicole Schneiderhan\u2010Marra","orcid":"https://orcid.org/0000-0001-6785-181X","observed_orcids":["https://orcid.org/0000-0001-6785-181X"]},"institutions":[{"id":"https://openalex.org/I4210111828","display_name":"Natural and Medical Sciences Institute","ror":"https://ror.org/01th1p123","country_code":"DE","type":"other","lineage":["https://openalex.org/I4210111828"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Nicole Schneiderhan-Marra","raw_affiliation_strings":["Natural and Medical Sciences Institute, Reutlingen, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Natural and Medical Sciences Institute, Reutlingen, Germany","institution_ids":["https://openalex.org/I4210111828"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5060545096","display_name":"Ina Schuppe\u2010Koistinen","orcid":"https://orcid.org/0000-0002-1423-3089","observed_orcids":["https://orcid.org/0000-0002-1423-3089","https://orcid.org/0000-0002-4742-448X"]},"institutions":[{"id":"https://openalex.org/I4210143795","display_name":"AstraZeneca (Sweden)","ror":"https://ror.org/04wwrrg31","country_code":"SE","type":"company","lineage":["https://openalex.org/I105036370","https://openalex.org/I4210143795"]}],"countries":["SE"],"is_corresponding":false,"raw_author_name":"Ina Schuppe-Koistinen","raw_affiliation_strings":["AstraZeneca R&D, So\u0308derta\u0308lje, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"AstraZeneca R&D, So\u0308derta\u0308lje, Sweden","institution_ids":["https://openalex.org/I4210143795"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5015663977","display_name":"Peter E. Thomann","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210111332","display_name":"Firalis (France)","ror":"https://ror.org/02s9z8855","country_code":"FR","type":"company","lineage":["https://openalex.org/I4210111332"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Peter Thomann","raw_affiliation_strings":["Firalis SAS, 35 rue du Fort, 68330 Huningue, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Firalis SAS, 35 rue du Fort, 68330 Huningue, France","institution_ids":["https://openalex.org/I4210111332"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5008269114","display_name":"Jean-Marc Vidal","orcid":"https://orcid.org/0000-0002-4422-5880","observed_orcids":["https://orcid.org/0000-0002-4422-5880"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jean-Marc Vidal","raw_affiliation_strings":["EMA, London, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"EMA, London, UK","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5014217787","display_name":"B\u00e9atrice Molac","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210111332","display_name":"Firalis (France)","ror":"https://ror.org/02s9z8855","country_code":"FR","type":"company","lineage":["https://openalex.org/I4210111332"]}],"countries":["FR"],"is_corresponding":true,"raw_author_name":"B\u00e9atrice Molac","raw_affiliation_strings":["Firalis SAS, 35 rue du Fort, 68330 Huningue, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Firalis SAS, 35 rue du Fort, 68330 Huningue, France","institution_ids":["https://openalex.org/I4210111332"]}]}],"institutions":[],"countries_distinct_count":7,"institutions_distinct_count":10,"corresponding_author_ids":["https://openalex.org/A5014217787"],"corresponding_institution_ids":["https://openalex.org/I4210111332"],"apc_list":{"value":4720,"currency":"USD","value_usd":4720},"apc_paid":null,"fwci":1.7831,"has_fulltext":false,"cited_by_count":76,"citation_normalized_percentile":{"value":0.84375,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":99},"biblio":{"volume":"16","issue":"13-14","first_page":"600","last_page":"608"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12281","display_name":"Animal testing and alternatives","score":0.6488999724388123,"subfield":{"id":"https://openalex.org/subfields/3404","display_name":"Small Animals"},"field":{"id":"https://openalex.org/fields/34","display_name":"Veterinary"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T12281","display_name":"Animal testing and alternatives","score":0.6488999724388123,"subfield":{"id":"https://openalex.org/subfields/3404","display_name":"Small Animals"},"field":{"id":"https://openalex.org/fields/34","display_name":"Veterinary"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11235","display_name":"Statistical Methods in Clinical Trials","score":0.09539999812841415,"subfield":{"id":"https://openalex.org/subfields/2613","display_name":"Statistics and Probability"},"field":{"id":"https://openalex.org/fields/26","display_name":"Mathematics"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T14072","display_name":"Immunotoxicology and immune responses","score":0.05979999899864197,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/biomarker-qualification","display_name":"biomarker qualification","score":0.9779999852180481},{"id":"https://openalex.org/keywords/drug-toxicity","display_name":"drug toxicity","score":0.9729999899864197},{"id":"https://openalex.org/keywords/drug-induced-injury","display_name":"drug-induced injury","score":0.6710000038146973},{"id":"https://openalex.org/keywords/clinical-trials","display_name":"clinical trials","score":0.6320000290870667},{"id":"https://openalex.org/keywords/clinical-trial-endpoints","display_name":"clinical trial endpoints","score":0.5289999842643738},{"id":"https://openalex.org/keywords/drug-safety","display_name":"drug safety","score":0.5979999899864197}],"concepts":[{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.5838059186935425},{"id":"https://openalex.org/C128544194","wikidata":"https://www.wikidata.org/wiki/Q474859","display_name":"Translational research","level":2,"score":0.5513477325439453},{"id":"https://openalex.org/C112930515","wikidata":"https://www.wikidata.org/wiki/Q4389547","display_name":"Risk analysis (engineering)","level":1,"score":0.49420931935310364},{"id":"https://openalex.org/C162264550","wikidata":"https://www.wikidata.org/wiki/Q17112037","display_name":"Translational medicine","level":2,"score":0.4487548768520355},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.44692158699035645},{"id":"https://openalex.org/C64903051","wikidata":"https://www.wikidata.org/wiki/Q2198549","display_name":"Drug development","level":3,"score":0.44285085797309875},{"id":"https://openalex.org/C116834253","wikidata":"https://www.wikidata.org/wiki/Q2039217","display_name":"Identification (biology)","level":2,"score":0.4358806610107422},{"id":"https://openalex.org/C2781050149","wikidata":"https://www.wikidata.org/wiki/Q552070","display_name":"Good laboratory practice","level":4,"score":0.43376290798187256},{"id":"https://openalex.org/C74187038","wikidata":"https://www.wikidata.org/wiki/Q1418791","display_name":"Drug discovery","level":2,"score":0.4298456013202667},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.40363872051239014},{"id":"https://openalex.org/C70721500","wikidata":"https://www.wikidata.org/wiki/Q177005","display_name":"Computational biology","level":1,"score":0.323490709066391},{"id":"https://openalex.org/C60644358","wikidata":"https://www.wikidata.org/wiki/Q128570","display_name":"Bioinformatics","level":1,"score":0.28782588243484497},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.25502246618270874},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.13265690207481384},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.12185043096542358},{"id":"https://openalex.org/C106436119","wikidata":"https://www.wikidata.org/wiki/Q836575","display_name":"Quality assurance","level":3,"score":0.11606729030609131},{"id":"https://openalex.org/C2778618615","wikidata":"https://www.wikidata.org/wiki/Q4008393","display_name":"External quality assessment","level":2,"score":0.0},{"id":"https://openalex.org/C59822182","wikidata":"https://www.wikidata.org/wiki/Q441","display_name":"Botany","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002986","descriptor_name":"Clinical Trials as Topic","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012107","descriptor_name":"Research Design","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015195","descriptor_name":"Drug Design","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017408","descriptor_name":"Guidelines as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D023381","descriptor_name":"Endpoint Determination","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D054316","descriptor_name":"Biomarkers, Pharmacological","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D064420","descriptor_name":"Drug-Related Side Effects and Adverse Reactions","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1016/j.drudis.2011.04.011","doi":"https://doi.org/10.1016/j.drudis.2011.04.011","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.drudis.2011.04.011","pdf_url":null,"source":{"id":"https://openalex.org/S152068293","display_name":"Drug Discovery Today","issn_l":"1359-6446","issn":["1359-6446","1878-5832"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-1","medline","norway-1","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Drug Discovery Today","raw_type":"journal-article"},{"id":"pmid:21570476","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/21570476","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Drug discovery today","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.98580002784729}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":19,"referenced_works":["https://openalex.org/W1486209493","https://openalex.org/W1952350108","https://openalex.org/W2002058320","https://openalex.org/W2003418600","https://openalex.org/W2010364063","https://openalex.org/W2013206130","https://openalex.org/W2029426756","https://openalex.org/W2046475112","https://openalex.org/W2050560466","https://openalex.org/W2060224146","https://openalex.org/W2066207224","https://openalex.org/W2078292938","https://openalex.org/W2118812883","https://openalex.org/W2121943809","https://openalex.org/W2132071446","https://openalex.org/W2141854336","https://openalex.org/W2155120951","https://openalex.org/W2164390107","https://openalex.org/W2486289350"],"related_works":["https://openalex.org/W1975994584","https://openalex.org/W3039580108","https://openalex.org/W2597676049","https://openalex.org/W120931395","https://openalex.org/W7073866220","https://openalex.org/W2122381317","https://openalex.org/W2079149444","https://openalex.org/W2930920482","https://openalex.org/W3136282903","https://openalex.org/W2770180713"],"abstract_inverted_index":null,"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":3},{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":3},{"year":2022,"cited_by_count":2},{"year":2020,"cited_by_count":1},{"year":2019,"cited_by_count":5},{"year":2018,"cited_by_count":8},{"year":2017,"cited_by_count":6},{"year":2016,"cited_by_count":11},{"year":2015,"cited_by_count":6},{"year":2014,"cited_by_count":10},{"year":2013,"cited_by_count":8},{"year":2012,"cited_by_count":9}],"updated_date":"2026-11-07T11:25:07.637180","created_date":"2016-06-24T00:00:00"}